Prognostic value of 18FDG PET-CT in patients with head and neck cancer candidates to radical radiotherapy (Abstract in rivista)

Type
Label
  • Prognostic value of 18FDG PET-CT in patients with head and neck cancer candidates to radical radiotherapy (Abstract in rivista) (literal)
Anno
  • 2012-01-01T00:00:00+01:00 (literal)
Alternative label
  • Paola Mapelli; Eleonora Grosso; Italo Dell'Oca; Maria Picchio; Isabella Castiglioni; Elena Busnardo; Elisa Villa; Margarita Kirienko; Luigi Gianolli; Cristina Messa. (2012)
    Prognostic value of 18FDG PET-CT in patients with head and neck cancer candidates to radical radiotherapy
    (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#autori
  • Paola Mapelli; Eleonora Grosso; Italo Dell'Oca; Maria Picchio; Isabella Castiglioni; Elena Busnardo; Elisa Villa; Margarita Kirienko; Luigi Gianolli; Cristina Messa. (literal)
Pagina inizio
  • Abstract 1348 (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroVolume
  • 53 (literal)
Rivista
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroFascicolo
  • Supplemento (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#affiliazioni
  • University of Milano-Bicocca, Milano, Italy. LATO s.c.a.r.l, Cefalù (PA), Italy. Radiation Oncology, Scientific Institute San Raffaele, Milan, Italy. Nuclear Medicine Department, Scientific Institute San Raffaele, Milan, Italy. IBFM-CNR, Milan, Italy. Nuclear Medicine Department, San Gerardo Hospital, Monza, Italy. Tecnomed Foundation, University of Milano-Bicocca, Milan, Italy. (literal)
Titolo
  • Prognostic value of 18FDG PET-CT in patients with head and neck cancer candidates to radical radiotherapy (literal)
Abstract
  • Objectives: To evaluate the predictive role of primary tumor and lymph-node uptake for disease-free survival (DFS) in head and neck cancer (HNC) patients (pts) candidates to radical RT. Methods: 25 HNC pts (median age 59.3 yrs, range: 23-81 yrs) treated with FDG PET/CT guided radical radiotherapy (2005-2011,simultaneous integrated boost (SIB) on PET positive sub-volume intensity-modulated radiotherapy (IMRT), 69Gy, 30 fractions),were retrospectively included. SUV,with and without Partial Volume Effect correction (PVC) and Biological Target Volume (BTV) (60% SUVmax) were calculated for both primary tumor and nodes (SUVT, SUVL and BTVT, BTVL, respectively) on pre-therapy FDG PET/CT, to identify SUV patient clusters.Two-year DFS was calculated for each cluster. Results: FDG PET/CT detected primary tumor in all 25 cases and cervical nodes in 17/25 pts (1 FP and 2 FN). SUVT correlated with SUVL, both with and without PVC (r=0.82, 0.76 respectively). Pts with negative nodes(G1) had SUVT<14 (SUVT<11 without PVC). SUVT did not correlate with BTVT and BTVL. Two separate clusters of SUV thresholds were found for pts with both PET positive tumour and nodes:G2) SUVT<17 and SUVL<13 (SUVT<14.6 and SUVL<11 without PVC) and G3)SUVT>17 and SUVL>13 (SUVT>14.6 and SUVL>13 without PVC). DFS was 55.5%,45.8% and 75% for G1,G2 and G3 when PVC was applied,while 55.5%,50.3%and 66.7% without PVC. Conclusions: Pretreatment SUV has a prognostic value for DFS in HNC pts candidates to RT. PVC is essential for accurate SUV measurement.A high primary tumor uptake (SUVT >17) is always associated with the presence of positive nodes (literal)
Prodotto di
Autore CNR

Incoming links:


Autore CNR di
Prodotto
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#rivistaDi
data.CNR.it